Literature DB >> 17060561

Effect of a clinical stroke on the risk of dementia in a prospective cohort.

A Gamaldo1, A Moghekar, S Kilada, S M Resnick, A B Zonderman, R O'Brien.   

Abstract

OBJECTIVE: To examine the risk and determinants of dementia following a clinically overt stroke in a prospectively followed cohort of elderly subjects.
METHODS: We examined the effect of a clinically detectable stroke on the risk of dementia using prospective data from 335 subjects in the Baltimore Longitudinal Study of Aging, all of whom were cognitively and neurologically normal at entry into the study (mean age at entry 75.1 +/- 4.2 years).
RESULTS: Clinically overt strokes are common in our cohort (cumulative risk by age 90, 15.4%; 95% CI: 10 to 22%) and confer an increased risk of dementia compared to subjects without stroke (odds ratio [OR] 5.55; 95% CI: 2.76 to 11.4). The majority of patients who became demented after a stroke had evidence of mild cognitive impairment preceding the stroke (14 of 19). Moreover, a clinically symptomatic stroke was a major risk factor for the conversion of mild cognitive impairment to dementia (OR 12.4; 95% CI: 1.5 to 99). When cognitive impairment did not precede the stroke, there was no increase in the risk of subsequent dementia. Pathologic data indicate that both vascular and Alzheimer pathology leads to the prestroke impairment.
CONCLUSION: Dementia after stroke may be determined by cognitive impairments that exist prior to the stroke.

Entities:  

Mesh:

Year:  2006        PMID: 17060561     DOI: 10.1212/01.wnl.0000240285.89067.3f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  38 in total

1.  Age, Alzheimer's disease and dementia in the Baltimore Longitudinal Study of Ageing.

Authors:  David Dolan; Juan Troncoso; Susan M Resnick; Barbara J Crain; Alan B Zonderman; Richard J O'Brien
Journal:  Brain       Date:  2010-07-20       Impact factor: 13.501

2.  When two are worse than one: stroke and Alzheimer disease.

Authors:  Charles S DeCarli
Journal:  Neurology       Date:  2006-10-24       Impact factor: 9.910

3.  Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.

Authors:  Yun Zhou; Susan M Resnick; Weiguo Ye; Hong Fan; Daniel P Holt; William E Klunk; Chester A Mathis; Robert Dannals; Dean F Wong
Journal:  Neuroimage       Date:  2007-03-16       Impact factor: 6.556

4.  Long-Term Risk of Dementia Among Survivors of Ischemic or Hemorrhagic Stroke.

Authors:  Priscila Corraini; Victor W Henderson; Anne G Ording; Lars Pedersen; Erzsébet Horváth-Puhó; Henrik T Sørensen
Journal:  Stroke       Date:  2016-11-29       Impact factor: 7.914

5.  Mild cognitive impairment and asymptomatic Alzheimer disease subjects: equivalent β-amyloid and tau loads with divergent cognitive outcomes.

Authors:  Diego Iacono; Susan M Resnick; Richard O'Brien; Alan B Zonderman; Yang An; Olga Pletnikova; Gay Rudow; Barbara Crain; Juan C Troncoso
Journal:  J Neuropathol Exp Neurol       Date:  2014-04       Impact factor: 3.685

6.  Long-term cognitive decline and mortality after carotid endarterectomy.

Authors:  Parthasarathy D Thirumala; Rajiv P Reddy; Oscar L Lopez; Yue-Fang Chang; James T Becker; Lewis H Kuller
Journal:  Clin Neurol Neurosurg       Date:  2020-04-06       Impact factor: 1.876

Review 7.  Epidemiology of Alzheimer disease.

Authors:  Richard Mayeux; Yaakov Stern
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

Review 8.  Secondary stroke prevention strategies for the oldest patients: possibilities and challenges.

Authors:  Cheryl D Bushnell; Cathleen S Colón-Emeric
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

9.  Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.

Authors:  Y-F Chuang; Y An; M Bilgel; D F Wong; J C Troncoso; R J O'Brien; J C Breitner; L Ferruci; S M Resnick; M Thambisetty
Journal:  Mol Psychiatry       Date:  2015-09-01       Impact factor: 15.992

10.  Beyond mild cognitive impairment: vascular cognitive impairment, no dementia (VCIND).

Authors:  Blossom Cm Stephan; Fiona E Matthews; Kay-Tee Khaw; Carole Dufouil; Carol Brayne
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.